TickerFactsScreenerDevelopers

Voyager Therapeutics, Inc. (VYGR) — Operating Income

Annual figures by fiscal year, from SEC filings.

2014: -$14.37M2015: -$20.25M2016: -$41.30M2017: -$71.86M2018: -$91.09M2019: -$51.68M2020: $27.38M2021: -$73.62M2022: -$50.84M2023: $122.01M2024: -$83.29M2025: -$131.84M-$131.84M
2014Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$131.84M-58.3%
2024-$83.29M-168.3%
2023$122.01M+340.0%
2022-$50.84M+30.9%
2021-$73.62M-368.8%
2020$27.38M+153.0%
2019-$51.68M+43.3%
2018-$91.09M-26.8%
2017-$71.86M-74.0%
2016-$41.30M-103.9%
2015-$20.25M-41.0%
2014-$14.37M—